aTYR PHARMA INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.2 | $0.2 | $0.4 | $10.4 | $0.0 |
| Operating income | -$77.6 | -$67.9 | -$54.9 | -$46.4 | -$34.0 |
| Net income | -$74.1 | -$64.0 | -$50.4 | -$45.3 | -$33.8 |
| Cash Flow Statement | |||||
| Free cash flow | -$62.1 | -$69.2 | -$37.4 | -$43.5 | -$33.3 |
Shares outstanding 98.1M · Free float 95.2%
Annual filing data through FY ended December 31, 2025; float as of August 25, 2026.